Approval · Notice of Compliance 9665 · 2008
ERWINASE: Notice of Compliance 9665
Issued July 8, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9665
- Date
- July 8, 2008
- Company
- Eusa Pharma SasLanghorne, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing process and equipment changes
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERWINASE | Not yet assigned | — |
Medicinal ingredients
- ASPARAGINASE 10,000 UNIT per VIAL